关于知识产权 知识产权培训 树立尊重知识产权的风尚 知识产权外联 部门知识产权 知识产权和热点议题 特定领域知识产权 专利和技术信息 商标信息 工业品外观设计信息 地理标志信息 植物品种信息(UPOV) 知识产权法律、条约和判决 知识产权资源 知识产权报告 专利保护 商标保护 工业品外观设计保护 地理标志保护 植物品种保护(UPOV) 知识产权争议解决 知识产权局业务解决方案 知识产权服务缴费 谈判与决策 发展合作 创新支持 公私伙伴关系 人工智能工具和服务 组织简介 与产权组织合作 问责制 专利 商标 工业品外观设计 地理标志 版权 商业秘密 WIPO学院 讲习班和研讨会 知识产权执法 WIPO ALERT 宣传 世界知识产权日 WIPO杂志 案例研究和成功故事 知识产权新闻 产权组织奖 企业 高校 土著人民 司法机构 遗传资源、传统知识和传统文化表现形式 经济学 金融 无形资产 性别平等 全球卫生 气候变化 竞争政策 可持续发展目标 前沿技术 移动应用 体育 旅游 PATENTSCOPE 专利分析 国际专利分类 ARDI - 研究促进创新 ASPI - 专业化专利信息 全球品牌数据库 马德里监视器 Article 6ter Express数据库 尼斯分类 维也纳分类 全球外观设计数据库 国际外观设计公报 Hague Express数据库 洛迦诺分类 Lisbon Express数据库 全球品牌数据库地理标志信息 PLUTO植物品种数据库 GENIE数据库 产权组织管理的条约 WIPO Lex - 知识产权法律、条约和判决 产权组织标准 知识产权统计 WIPO Pearl(术语) 产权组织出版物 国家知识产权概况 产权组织知识中心 产权组织技术趋势 全球创新指数 世界知识产权报告 PCT - 国际专利体系 ePCT 布达佩斯 - 国际微生物保藏体系 马德里 - 国际商标体系 eMadrid 第六条之三(徽章、旗帜、国徽) 海牙 - 国际外观设计体系 eHague 里斯本 - 国际地理标志体系 eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange 调解 仲裁 专家裁决 域名争议 检索和审查集中式接入(CASE) 数字查询服务(DAS) WIPO Pay 产权组织往来账户 产权组织各大会 常设委员会 会议日历 WIPO Webcast 产权组织正式文件 发展议程 技术援助 知识产权培训机构 COVID-19支持 国家知识产权战略 政策和立法咨询 合作枢纽 技术与创新支持中心(TISC) 技术转移 发明人援助计划(IAP) WIPO GREEN 产权组织的PAT-INFORMED 无障碍图书联合会 产权组织服务创作者 WIPO Translate 语音转文字 分类助手 成员国 观察员 总干事 部门活动 驻外办事处 职位空缺 采购 成果和预算 财务报告 监督
Arabic English Spanish French Russian Chinese
法律 条约 判决 按管辖区浏览

生物技术发明法律保护法令, 斯洛文尼亚

返回
WIPO Lex中的最新版本
详情 详情 版本年份 2003 日期 生效: 2003年9月2日 文本类型 实施规则/实施细则 主题 专利(发明)

可用资料

主要文本 相关文本
主要文本 主要文本 英语 Decree on the Legal Protection of Biotechnological Inventions        
 
下载PDF open_in_new
 SI034: Patents, Legal Protection of Biotechnological Inventions

On the basis of the second paragraph of Article 10 of the Industrial Property Act (Official

Gazette of the Republic of Slovenia, No. 7/03), the Government of the Republic of Slovenia

hereby issues the following

DECREE 1

ON THE LEGAL PROTECTION OF BIOTECHNOLOGICAL INVENTIONS

Article 1

This Decree defines detailed conditions for the grant of patents for biotechnological

inventions, which have to be fulfilled beside those prescribed by the Industrial Property Act.

Article 2

(1) For the purposes of this Decree,

(a) “biological material” means any material containing genetic information and capable of

reproducing itself or being reproduced in a biological system;

(b) “microbiological process” means any process involving or performed upon or resulting in

microbiological material.

(2) A process for the production of plants or animals is essentially biological if it consists

entirely of natural phenomena such as crossing or selection.

(3) “Variety” shall be taken to mean a plant grouping within a single botanical taxon of the

lowest known rank, which grouping, irrespective of whether the conditions for the grant of a

plant variety right are fully met, can be:

(a) defined by the expression of the characteristics that results from a given genotype or

combination of genotypes,

(b) distinguished from any other plant grouping by the expression of at least one of the said

characteristics, and

(c) considered as a unit with regard to its suitability for being propagated unchanged.

Article 3

(1) For the purposes of this Decree, inventions which are new, which involve an inventive

step and which are susceptible of industrial application shall be patentable even if they

concern a product consisting of or containing biological material or a process by means of

which biological material is produced, processed or used.

1 Published in the Official Gazette RS, No. 81/03. Entry into force: 2 September 2003.

(2) Biological material which is isolated from its natural environment or produced by means

of a technical process may be the subject of an invention even if it previously occurred in

nature.

Article 4

(1) The following shall not be patentable:

(a) plant and animal varieties; and

(b) essentially biological processes for the production of plants or animals.

(2) Inventions which concern plants or animals shall be patentable if the technical feasibility

of the invention is not confined to a particular plant or animal variety.

(3) Paragraph 1(b) shall be without prejudice to the patentability of inventions which concern

a microbiological or other technical process or a product obtained by means of such a process.

Article 5

(1) The human body, at the various stages of its formation and development, and the simple

discovery of one of its elements, including the sequence or partial sequence of a gene, cannot

constitute patentable inventions.

(2) An element isolated from the human body or otherwise produced by means of a technical

process, including the sequence or partial sequence of a gene, may constitute a patentable

invention, even if the structure of that element is identical to that of a natural element.

(3) The industrial application of a sequence or a partial sequence of a gene must be disclosed

in the patent application.

Article 6

(1) Inventions shall be considered unpatentable where their commercial exploitation would be

contrary to ordre public or morality; however, exploitation shall not be deemed to be so

contrary merely because it is prohibited by law or regulation.

(2) On the basis of paragraph 1, the following, in particular, shall be considered unpatentable:

(a) processes for cloning human beings;

(b) processes for modifying the germ line genetic identity of human beings;

(c) uses of human embryos for industrial or commercial purposes;

(d) processes for modifying the genetic identity of animals which are likely to cause them

suffering without any substantial medical benefit to man or animal, and also animals resulting

from such processes.

Article 7

(1) The protection conferred by a patent on a biological material possessing specific

characteristics as a result of the invention shall extend to any biological material derived from

that biological material through propagation or multiplication in an identical or divergent

form and possessing those same characteristics.

(2) The protection conferred by a patent on a process that enables a biological material to be

produced possessing specific characteristics as a result of the invention shall extend to

biological material directly obtained through that process and to any other biological material

derived from the directly obtained biological material through propagation or multiplication in

an identical or divergent form and possessing those same characteristics.

Article 8

The protection conferred by a patent on a product containing or consisting of genetic

information shall extend to all material, save as provided in Article 5(1), in which the product

in incorporated and in which the genetic information is contained and performs its function.

Article 9

The protection referred to in Articles 7 and 8 shall not extend to biological material obtained

from the propagation or multiplication of biological material placed on the market in the

territory of the Republic of Slovenia by the holder of the patent or with his consent, where the

multiplication or propagation necessarily results from the application for which the biological

material was marketed, provided that the material obtained is not subsequently used for other

propagation or multiplication.

Article 10

(1) By way of derogation from Articles 7 and 8, the sale or other form of commercialisation

of plant propagating material to a farmer by the holder of the patent or with his consent for

agricultural use implies authorisation for the farmer to use the product of his harvest,

according to Article 16 of the Protection of New Plant Varieties Act, for propagation or

multiplication by him on his own farm.

(2) By way of derogation from Articles 7 and 8, the sale or any other form of

commercialisation of breeding stock or other animal reproductive material to a farmer by the

holder of the patent or with his consent implies authorisation for the farmer to use the

protected livestock for an agricultural purpose. This includes making the animal or other

animal reproductive material available for the purposes of pursuing his agricultural activity

but not sale within the framework or for the purpose of a commercial reproduction activity.

Article 11

(1) Where a breeder cannot acquire or exploit a plant variety right without infringing a prior

patent, he may apply for a compulsory licence for non-exclusive use of the invention

protected by the patent inasmuch as the licence is necessary for the exploitation of the plant

variety to be protected, subject to payment of an appropriate royalty.

(2) Where the holder of a patent concerning a biotechnological invention cannot exploit it

without infringing a prior plant variety right, he may apply for a compulsory licence for non-

exclusive use of the plant variety protected by that right, subject to payment of an appropriate

royalty.

(3) Applicants for the licences referred to in paragraphs 1 and 2 must demonstrate that:

(a) they have applied unsuccessfully to the holder of the patent or of the plant variety right to

obtain a contractual licence;

(b) the plant variety or the invention constitutes significant technical progress of considerable

economic interest compared with the invention claimed in the patent or the protected plant

variety.

Article 12

Applications for patents for biotechnological inventions which were filed before the date of

entry into force of this Decree shall be treated in accordance with the provisions of this

Decree.

Article 13

This Decree shall enter into force on the fifteenth day following its publication in the Official

Gazette of the Republic of Slovenia.


无可用数据。

WIPO Lex编号 SI034